Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

The diagnostic performance of the iFR makes the FFR tremble

Despite the evidence, most stable patients continue to be managed based on coronary angiography and, worse, often without a prior non-invasive functional study.

La performance diagnóstica del iFR hace temblar al FFR

With the introduction of the FFR, we left the “anatomical” era for the “functional” era in the catheterization room, which has been proven to improve patients prognosis and, as if that were not enough, is saving costs.


Read also: New FFR Measuring Device to Guide Coronary Revascularization with Our Preferred Wire.


Despite all of the above, the FFR continues to be used occasionally worldwide, and perhaps, one of the reasons, it is somewhat cumbersome to use it, and it is necessary to invest time in this.

 

As an alternative to FFR, the index measured in the free wave period (instantaneous wave-free ratio, iFR) emerged, which has the advantage of not needing hyperemia, so we save adenosine (both in cost and in symptoms) and make functional assessment faster and easier.

  

The objective of this work was to perform a meta-analysis of all the works that compared the FFR with the iFR to know if we can really change from gold standard to functional assessment.


Read also: What Is the Long-Term Outcome of Lesions Deferred Using FFR/iFR?


A total of 23 studies with 6381 stenoses were included, with a first meta-analysis of all the studies to explore the correlation between both indices. Results showed that this correlation was very good (0.798, CI 95% 0.78 to 0.82, p<0.001). Additionally, the diagnostic performance of iFR was evaluated to identify coronary lesions with positive FFR. This, like correlation, was also very good with an area under the curve of 0.88 (p <0.001).

 

Conclusion

The present meta-analysis shows that iFR correlates significantly with FFR and shows a very good diagnostic accuracy to identify lesions with positive FFR. Finally, the iFR and the FFR showed that they have a similar diagnostic efficacy to detect ischemic lesions. This was observed when compared to a third parameter with coronary flow measured by Doppler.

Editorial Comment

The analysis confirms the good correlation between FFR and iFR, although this is not perfect and there will always be some degree of divergence; which initially worried. However, studies using a third validated method to detect ischemia such as positron emission tomography and coronary flow measurement with Doppler, showed that when there was divergence between both indices, half of the time the third method coincided with the FFR and the other half with the iFR.


Read also: What is the effect of statins on amputations, and survival in peripheral vascular disease?


This would make the hybrid evaluation that we suggested in the early days of the iFR, unnecessary where the intermediate values of the same (0.86 to 0.94) should be confirmed with FFR and adenosine.

 

Additionally, recent studies such as DEFINE-Flair and iFR-SWEDEHEART confirmed non-inferiority in terms of clinical events when using iFR versus FFR.

 

Original Title: Diagnostic Performance of the Instantaneous Wave-Free Ratio Comparison With Fractional Flow Reserve.

Reference: Salvatore De Rosa et al. Circ Cardiovasc Interv. 2018 Jan; 11(1):e004613.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...

EuroPCR 2026 | TAVI and Coronary Artery Disease: FFR-Guided PCI Showed Better Outcomes Than an Angiography-Guided Strategy

In patients undergoing TAVI, the concomitant presence of coronary artery disease continues to generate debate: whether coronary lesions should be treated before, during, or...

EuroPCR 2026 | Evolocumab Reduces Cardiovascular Events in Patients With Prior PCI Without Previous Myocardial Infarction: VESALIUS-CV Results

This presentation, delivered by Dr. Brian A. Bergmark and colleagues at EuroPCR 2026, detailed the results of the VESALIUS-CV trial, focusing specifically on the...

EuroPCR 2026 | Is It Safe to Stop Aspirin After One Month in MI Patients Undergoing PCI? TARGET-FIRST Analysis

This is a summary of the post-hoc analysis of the TARGET-FIRST study, presented by Dr. Giuseppe Tarantini at EuroPCR 2026, evaluating early aspirin discontinuation...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...